India's Bharat Parenteral rebounds on successful completion of EU GMP inspection

Bharat Parenterals

28/11/2025 09:03

**Shares of Bharat Parenteral BATP.BO jump as much as 10% to 1216 rupees, reversing earlier losses; last up 5.4%

**Pharma co says Belgium's medicine and health body completed the European Union Good Manufacturing Practice (EU GMP) inspection at its manufacturing facility in Vadodara, Gujarat state

**Co says audit was completed with no critical or major observations

**Successful completion comes after its successful US FDA inspection

**YTD, however, stock is down 25.9%

 (Reporting by Mridula Kumar in Bengaluru)

 ((Mridula.Kumar@thomsonreuters.com;))